Hi All,

I'm going to provide an unofficial statement, not so much about POET or what they are doing but re: Wall Street and small growing Companies. One of the things that a small pre-revenue Company must focus on is actually not having too many irons in the fire.

For Wall Street and the entire point of a for profit operating Company, this comes down to execution. Development Companies, I.E. Biotech have limited budgets and therefore management must find the shortest path to a revenue stream. This is balanced against the backdrop of getting a fair valuation for the Company's IP vs the Company's cash burn and how much time is allotted in returning value back to shareholders.

Revenue proves - proof of concept and therefore makes the cost of capital (raising money for further development) much cheaper for any Company in addition to creating a revenue stream that can also drive growth and further product development. Just something to think about as a backdrop. These are things a Management team at small Companies must think about.

If a Company adds another development idea then would POET be diluting their message and focus of their original strategic plan? Everything for Companies such as POET comes down to planning a strategy and delivering a promise that their strategy will get executed.